Atlas Trials

Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease

Clinical trial NCT01453569 · COMPLETED

Trial details

NCT number
NCT01453569
Sponsor
Shanghai Greenvalley Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer DiseaseCognitive Impairment
Start date
2011-10-01
Primary completion
2013-08-01
Enrollment
255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.